Melarsoprol Cyclodextrin Inclusion Complexes as Promising Oral Candidates for the Treatment of Human African Trypanosomiasis

• Jean Rodgers ,

  Contributed equally to this work with: Jean Rodgers, Amy Jones

  Affiliation Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Amy Jones ,

  Contributed equally to this work with: Jean Rodgers, Amy Jones

  Affiliation Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Stéphane Gibaud,

  Affiliation Laboratoire de Pharmacie Clinique, Nancy Université, Nancy, France

  ⨯
• Barbara Bradley,

  Affiliation Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Christopher McCabe,

  Affiliation Institute of Neuroscience and Psychology, Glasgow Experimental MRI Centre, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Michael P. Barrett,

  Affiliation Wellcome Trust Centre of Molecular Parasitology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

  ⨯
• George Gettinby,

  Affiliation Department of Mathematics and Statistics, University of Strathclyde, Glasgow, United Kingdom

  ⨯
• Peter G. E. Kennedy

  * E-mail: Peter.Kennedy@glasgow.ac.uk

  Affiliation Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

  ⨯